Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2012 Nov 15.

Published in final edited form as: J Immunol. 2012 Apr 13;188(10):5054–5062. doi: 10.4049/jimmunol.1102710

Table I.

Baseline characteristics of subjects

		RTS,S/AS01E n= 81	Control n=104
Age (months)^*		11.7 (± 0.4)	11.9 (± 0.3)
Sex (% Female)		52.5	48.1
[Hb] (g/dL)^*		10.6 (± 1.1)	10.7 (± 1.0)
WBC(10⁻⁹/L)^*		9.9 (± 3.3)	9.6 (± 3.4)
P. falciparum positive (n) ^**		0	1
Anti- HBSAg Ab titre (U/ml) ^***	Pre-vacc	148 (43-382)	258 (87-643)
	Month 3	48489 (4708 -132314)	213 (77-475)^†
	Month 12	9357 (3937-16269)	148 (33-436)^†
Anti-CS Ab titre (U/ml) ^***	Pre-vacc	0.25 (0.25 – 0.25)	0.25 (0.25 – 0.25)
	Month 3	506 (314-814)	0.25 (0.25 – 0.25)^†
	Month 12	37 (23-58)	0.25 (0.25 – 0.25)^†

^*

Mean (SD)

^**

Microscopic analysis of Giemsa-stained blood smears

^***

Median values plus interquartile ranges (25%-75%)

^†

Titres are significantly higher in RTS,S/AS01 vaccinees than controls (p ≤ 0.01)